NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in Myeloma or Lymphoma

OPTIMAL-HiChemo

NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

NCT04459416: Phase 3: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by relieving pain. Researchers also want to find out more about the effects of acupuncture treatments on other symptoms caused by cancer treatments and quality of life.

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Patient-Centered Outcomes Research Institute

Hackensack Meridian Health

---

ClinicalTrials.gov Identifier: NCT04459416

Official Title: Opioid-Sparing Pain Treatment In Myeloma And Lymphoma Patients Undergoing High-Dose Chemotherapy (OPTIMAL-HiChemo): Randomized Controlled Trial

First Posted : July 7, 2020

Click here for details on ClinicalTrials.gov

---

Other: Acupuncture

Drug: opioid

Other: Assessments

---

- New York: Memorial Sloan-Kettering Cancer Center New York

---

Location

United States, New York

United States, Washington